top of page
About
Committee
Consultancy
Fundraising
Legacy Gifting
Research
Project T21
Drug Science Journal
Medical Cannabis Working Group
Medical Psychedelics Working Group
Enhanced Harm Reduction Working Group
Community
Students
Events
Education
Drug Information
UK Psychedelic Training
Podcast
Blog
Bookshop
Modules
Street Drug Discussions
Donate
Profile
Profile
Join date: Feb 27, 2026
Posts
(1)
Feb 27, 2026
∙
5 min
From psychedelic trips to treating Treatment-Resistant Depression. The possible gamechanger COMP360
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
85
0
About
Committee
Consultancy
Fundraising
Legacy Gifting
Research
Project T21
Drug Science Journal
Medical Cannabis Working Group
Medical Psychedelics Working Group
Enhanced Harm Reduction Working Group
Community
Students
Events
Education
Drug Information
UK Psychedelic Training
Podcast
Blog
Bookshop
Modules
Street Drug Discussions
bottom of page
